Accumulation and activation-induced release of preformed fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2936-2941

  Wasem, C ^a   Frutschi, C ^a   Arnold, D ^a   Vallan, C ^a   Lin, T ^a   Green, D R ^a   Mueller, C ^a   Brunner, T ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FAS ANTIGEN; LIGAND;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL KILLING; CELL MEDIATED CYTOTOXICITY; COMPLEMENT ACTIVATION; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TISSUE INJURY;

EID: 0035451692     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2936     Document Type: Article

References (38)

1. Lymphocyte granule-mediated apoptosis: Matters of viral mimicry and deadly proteases
2. Fas and Fas ligand in gut and liver
3. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes: Participation in intestinal graft-versus-host disease
4. A major role for the Fas pathway in acute graft-versus-host disease
5. + T cell activation and IFN-γ production
6. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice
7. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation
8. Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies
9. Cytotoxic T cells deficient in both functional fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
10. Kinetics of intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice
11. Fas-FasL interactions: A common pathogenetic mechanism in organ-specific autoimmunity
12. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
13. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB
14. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative ipr and gld T cells
15. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression
16. The mechanism of action of cyclosporin A and FK506
17. Cyclosporin A and FK506: Molecular mechanisms of immunosuppression and probes for transplantation biology
18. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB
19. T cell receptor-induced fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
20. Activation-induced cell death in murine T cell hybridomas: Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506
21. Autocrine T-cell suicide mediated by APO-1/Fas (CD95)
22. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and nature killer cells
23. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
24. 2+independent T cell-mediated cytotoxicity
25. Transforming growth factor β1 inhibits fas ligand expression and subsequent activation-induced cell death in T cells via down-regulation of c-Myc
26. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1
27. The regulation of CD95 ligand expression and function in CTL
28. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively
29. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases
30. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity
31. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
32. The role of FasL-induced apoptosis in immune privilege
33. Regulation of CD95 ligand expression: A key element in immune regulation?
34. Is autoimmunity coming to a Fas(t) end?
35. Expression of Fas ligand in activated T cells is regulated by c-Myc
36. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression
37. A 'non-canonical' DNA-binding element mediates the response of the fas-ligand promoter to c-Myc
38. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ